Golden State Equity Partners Mirum Pharmaceuticals, Inc. Transaction History
Golden State Equity Partners
- $470 Million
- Q2 2024
A detailed history of Golden State Equity Partners transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Golden State Equity Partners holds 19,930 shares of MIRM stock, worth $782,451. This represents 0.14% of its overall portfolio holdings.
Number of Shares
19,930
Previous 18,930
5.28%
Holding current value
$782,451
Previous $558,000
22.04%
% of portfolio
0.14%
Previous 0.14%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
173Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$255 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$196 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$172 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$142 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.44B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...